EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Control of Mycobacterium tuberculosis infection in the elderly: Is there a role for epigenetic reprogramming reversal?

Dámaris P Romero-Rodríguez iD, Carlos A Díaz-Alvarado iD, Héctor Isaac Rocha-González iD, Esmeralda Juárez iD

BioFactors · 2025-01 · 51 (1)

DOI: 10.1002/biof.2151 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift BioFactors, online erschienen am 30.01.2025. Verfasst von Dámaris P Romero-Rodríguez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio Nacional Conahcyt de Investigación y Diagnóstico por Inmunocitofluorometría (LANCIDI), Laboratorio de Citometría de Flujo, Instituto Naci…. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Epigenesis, Genetic, Tuberculosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 145 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the increase in the elderly population worldwide, the number of subjects suffering from tuberculosis (TB) has shown an increased prevalence in this group. Immunosenescence is essential in this phenomenon because it may reactivate the lesions and render their adaptive immunity dysfunctional. In addition, inflammation in the lungs of the elderly subjects is also dysfunctional. Although effective drugs are available, they are often tolerated inadequately, reducing adherence to the therapy and leading to therapeutic failure. Comorbidities, poor general health status, and other medications may lead to increased drug adverse reactions and reduced adherence to treatment in the elderly. Hence, older adults require an individualized approach for better outcomes. Trained immunity, which involves epigenetic reprogramming, may contribute to balancing the dysfunction of innate and adaptive immunity in older people. This review analyzes the relationship between inflammation, age, and Mycobacterium tuberculosis . Moreover, we hypothesize that immunomodulation using trained immunity activators will help reduce inflammation while enhancing antimicrobial responses in the elderly. Understanding immunomodulation's molecular and physiological effects will lead to informed decisions about TB prevention and treatment strategies uniquely designed for the elderly.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisEpigenesis, GeneticTuberculosisHumansAgedAdaptive ImmunityImmunity, InnateImmunosenescenceInflammationAgingImmunomodulation

Stichwörter der Autor:innen

elderlyepigenetic reprogrammingimmunosenescencetrained immunitytuberculosis

Autor:innen und Institutionen

  • Laboratorio Nacional Conahcyt de Investigación y Diagnóstico por Inmunocitofluorometría (LANCIDI), Laboratorio de Citometría de Flujo, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Ciudad de Mé…
  • Benemérita Universidad Autónoma de Puebla, Ciudad de México, Mexico.
  • Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Ciudad de México, Mexico.
  • Laboratorio BSL3, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Ciudad de México, Mexico.

ORCID-Profile: Dámaris P Romero-Rodríguez, Carlos A Díaz-Alvarado, Héctor Isaac Rocha-González, Esmeralda Juárez

Zitieren

APA

Romero-Rodríguez, D. P., Díaz-Alvarado, C. A., Rocha-González, H. I., & Juárez, E. (2025). Control of Mycobacterium tuberculosis infection in the elderly: Is there a role for epigenetic reprogramming reversal?. BioFactors, 51(1). https://doi.org/10.1002/biof.2151

Vancouver

Romero-Rodríguez DP, Díaz-Alvarado CA, Rocha-González HI, Juárez E. Control of Mycobacterium tuberculosis infection in the elderly: Is there a role for epigenetic reprogramming reversal?. BioFactors. 2025;51(1). doi:10.1002/biof.2151

BibTeX
@article{RomeroRodrguez2025,
  author = {Romero-Rodríguez, Dámaris P and Díaz-Alvarado, Carlos A and Rocha-González, Héctor Isaac and Juárez, Esmeralda},
  title = {Control of Mycobacterium tuberculosis infection in the elderly: Is there a role for epigenetic reprogramming reversal?},
  journal = {BioFactors},
  year = {2025},
  volume = {51},
  number = {1},
  doi = {10.1002/biof.2151}
}
Kostenlos starten →